Postoperative radiation as adjuvant treatment for carcinoma of the oral cavity larynx, and pharynx: Preliminary report of a prospective randomized trial-Reference-Cited by-同舟云学术

Postoperative radiation as adjuvant treatment for carcinoma of the oral cavity larynx, and pharynx: Preliminary report of a prospective randomized trial

Published:1988-06 Issue:2 Volume:38 Page:71-76
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Kokal William A.,Neifeld James P.,Eisert Donald,Lipsett James A.,Lawrence Walter,Beatty J. David,Parker George A.,Pezner Richard D.,Riihimaki Daniel U.,Terz Jose J.

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference18 articles.

1. The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers

2. Results of a randomized clinical trial of preoperative irradiation versus postoperative in treatment of tumors of the hypopharynx

3. Advanced Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Treated with Irradiation and Surgery

4. Failure at the primary site following multimodality treatment in advanced head and neck cancer

5. Changing trends in the management of squamous carcinoma of the tongue

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment modalities, surgical principles, and rehabilitation considerations in head and neck cancer;Head and Neck Cancer Rehabilitation;2025

2. Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria;Head & Neck;2020-10-23

3. Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial;Radiation Oncology;2020-08-14

4. Postoperative radiotherapy (PORT) for early oral cavity cancer (pT1-2,N0-1): A review;Critical Reviews in Oncology/Hematology;2019-11

5. Assessment of adjuvant therapy in resected head and neck cancer with high-risk features;Oral Oncology;2017-11